Related Experiment Video
Updated: Sep 26, 2026

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
Published on: November 21, 2025
Coronary microembolization
Andreas Skyschally1, Raimund Erbel, Gerd Heusch
1Institut für Pathophysiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Germany.
Insights
Atherosclerotic plaque rupture can cause coronary microembolization, leading to infarctlets and arrhythmias. This review covers evidence and prevention strategies for this condition in acute coronary syndromes.
Area of Science:
- Cardiology
- Pathophysiology
- Medical Research
Background:
- Atherosclerotic plaque rupture is central to acute coronary syndromes.
- Plaque rupture can lead to microembolization into the coronary microcirculation, not always complete occlusion.
Purpose of the Study:
- To review morphological, experimental, and clinical evidence of coronary microembolization.
- To highlight key clinical features and prevention strategies for coronary microembolization.
Main Methods:
- Morphological analysis of coronary microembolization in deceased patients.
- Experimental studies in animal models of acute coronary syndromes and heart failure.
- Review of clinical evidence and features of coronary microembolization.
Main Results:
- Morphological evidence supports coronary microembolization in coronary artery disease.
- Animal models demonstrate the pathophysiology of microembolization.
- Clinical features include arrhythmias, contractile dysfunction, infarctlets, and reduced coronary reserve.
Conclusions:
- Coronary microembolization is a significant consequence of plaque rupture.
- Understanding its features aids in diagnosis and management.
- Mechanical devices and glycoprotein IIb/IIIa inhibitors show promise for prevention.
Abstract:
Atherosclerotic plaque rupture is a key event in the pathogenesis of acute coronary syndromes and during coronary interventions. However, it does not always result in complete thrombotic occlusion of the entire epicardial coronary artery with subsequent acute myocardial infarction; in milder forms the result can be embolization of atherosclerotic and thrombotic debris into the coronary microcirculation. This review summarizes the available morphological evidence for coronary microembolization in patients who died from coronary artery disease, most notably from sudden death, and then goes on to address the experimental pathophysiology of coronary microembolization in animal models of acute coronary syndromes and heart failure. Finally, the review presents the available clinical evidence for coronary microembolization in patients, highlights its key features (ie, arrhythmias, contractile dysfunction, infarctlets and reduced coronary reserve) and addresses its prevention by mechanical protection devices and glycoprotein IIb/IIIa antagonism.
Related Concept Videos
Pulmonary Embolism I: Introduction
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease II: Pathophysiology
Myocarditis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
